Form 4 for DNLI Denali Therapeutics Inc.
Accepted 2022-06-06 00:00:00 ET · period of report 2022-06-02 · accession 0001714899-22-000098 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-06 | 2022-06-02 | DNLI | Schenkein David P | Dir | A - Grant | $0.00 | +5,986 | 11.3K | +112% | $0 |
| D | 2022-06-06 | 2022-06-02 | DNLI | Schenkein David P | Dir | A - Grant | $0.00 | +18.0K | 18.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-02 | A | A | 5,986 | $0.00 | 11,313 | D | — | — | (F1) Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. (F2) Includes 5,986 unvested restricted stock units. |
| 2 | Derivative | Stock Option (right to buy) | 2022-06-02 | A | A | 17,959 | $0.00 | 17,959 | D | $24.27 · — to 2032-06-02 | 17,959 Common Stock | (F5) 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. |